Shock and shake: new combo therapy aims to rebuild muscle after brain bleed

NCT ID NCT03201094

Recruiting now Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving patients electrical muscle stimulation and high-protein shakes soon after a type of stroke (aneurysmal subarachnoid hemorrhage) can prevent muscle loss and improve recovery. Thirty adults will receive the combo therapy or standard care. The main goal is to see if muscle thickness changes, measured by ultrasound.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Neuromuscular electrical stimulation and high-protein whey shakes
What this could lead to: If it works, this could point toward a simple, early intervention to reduce muscle wasting and improve recovery after a severe brain bleed.
What could go wrong: This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The interventions are supportive and not expected to change the brain injury itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage Inflammation inflammatory disease metabolic disease muscular atrophy subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATION MUSCLE ATROPHY NUTRITIONAL AND METABOLIC DISEASE SUBARACHNOID HEMORRHAGE

Contacts and locations

Locations

University of Maryland Medical Center
RECRUITING

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.